PAR-1 antagonist vorapaxar favorably improves global thrombotic status in patients with coronary disease
Rosser, G., Tricoci, P., Morrow, D., Christopoulos, C., Niespialowska-Steuden, M., Kozarski, R., Wilcox, R. & Gorog, D. 2014In : Journal of Thrombosis and Thrombolysis.Research output: Contribution to journal› Article
| Original language | English |
|---|---|
| Journal | Journal of Thrombosis and Thrombolysis |
| Journal publication date | 2014 |
| DOIs | |
| State | In press |